HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kanzler Selected Research

Fluorouracil (Carac)

6/2011Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II study.
1/2010A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Kanzler Research Topics

Disease

8Neoplasms (Cancer)
10/2020 - 05/2001
5Liver Diseases (Liver Disease)
07/2008 - 04/2000
4Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 08/2006
3Disease Progression
10/2020 - 11/2001
3Adenocarcinoma
01/2018 - 01/2010
3Autoimmune Hepatitis
08/2002 - 04/2000
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2018
2Exanthema (Rash)
01/2021 - 01/2018
2Thrombosis (Thrombus)
08/2007 - 03/2007
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2007 - 11/2001
2Hemorrhage
10/2006 - 11/2004
2Fibrosis (Cirrhosis)
11/2001 - 05/2001
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021
1Pain (Aches)
01/2018
1Neoplasm Metastasis (Metastasis)
12/2014
1Lymphatic Metastasis
12/2014
1Biliary Tract Neoplasms (Biliary Tract Cancer)
12/2014
1Stomach Neoplasms (Stomach Cancer)
06/2011
1Necrosis
02/2010
1Cholangiocarcinoma
11/2007
1Anaphylaxis (Anaphylactic Shock)
11/2007
1Acute Liver Failure (Fulminant Hepatic Failure)
11/2007
1Portal Hypertension
08/2007
1Carcinoma (Carcinomatosis)
04/2007
1Ulcer
10/2006
1Cardiovascular Diseases (Cardiovascular Disease)
11/2004
1Esophagitis
01/2004
1Ureteral Calculi
12/2003
1Chronic Hepatitis C
11/2001
1Infections
11/2001
1Hepatitis C
11/2001
1Hepatocellular Carcinoma (Hepatoma)
08/2001
1Carcinogenesis
08/2001
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/2001
1Chronic Hepatitis B
08/2000

Drug/Important Bio-Agent (IBA)

3GemcitabineFDA Link
01/2021 - 12/2014
3Irinotecan (Camptosar)FDA LinkGeneric
06/2011 - 01/2010
3AutoantibodiesIBA
01/2004 - 04/2000
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2017 - 08/2001
2Biomarkers (Surrogate Marker)IBA
12/2014 - 06/2011
2Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2013 - 02/2010
2Capecitabine (Xeloda)FDA Link
09/2013 - 01/2010
2Fluorouracil (Carac)FDA LinkGeneric
06/2011 - 01/2010
2Azathioprine (Imuran)FDA LinkGeneric
10/2006 - 05/2001
2AntigensIBA
08/2002 - 04/2000
2liver antigen LA-1IBA
08/2002 - 04/2000
2Transforming Growth Factor beta (TGF-beta)IBA
11/2001 - 08/2001
1AfatinibIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Panitumumab (Vectibix)FDA Link
10/2020
1folfirinoxIBA
01/2018
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2018
1Transcription Factor 3IBA
01/2017
1Sorafenib (BAY 43-9006)FDA Link
12/2014
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2014
1Imatinib Mesylate (Gleevec)FDA Link
09/2013
1Bevacizumab (Avastin)FDA Link
09/2013
1XELOXIBA
09/2013
1ErbB Receptors (EGF Receptor)IBA
06/2011
1Cetuximab (Erbitux)FDA Link
06/2011
1Leucovorin (Folinic Acid)FDA Link
06/2011
1Monoclonal AntibodiesIBA
02/2010
1LigandsIBA
02/2010
1mapatumumabIBA
02/2010
1Cisplatin (Platino)FDA LinkGeneric
01/2010
1Mitomycin (Mitomycin-C)FDA LinkGeneric
11/2007
1Ethiodized Oil (Ethiodol)FDA Link
11/2007
1BilirubinIBA
08/2007
1Somatostatin Receptors (Somatostatin Receptor)IBA
04/2007
1SteroidsIBA
10/2006
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
11/2004
1AnticoagulantsIBA
11/2004
1AcidsIBA
01/2004
1AntibodiesIBA
08/2002
1EnzymesIBA
08/2002
1C-Reactive ProteinIBA
08/2001
1Phenobarbital (Luminal)FDA Link
08/2001
1CarcinogensIBA
08/2001
1Protein Isoforms (Isoforms)IBA
08/2001
1Transforming Growth Factor-beta Type II ReceptorIBA
08/2001
1Lamivudine (Epivir)FDA Link
08/2000

Therapy/Procedure

6Therapeutics
01/2021 - 05/2001
1Drug Therapy (Chemotherapy)
02/2010
1Conscious Sedation
07/2008
1Palliative Care (Palliative Therapy)
11/2007
1Contraindications
08/2007
1Immunotherapy
08/2006
1Endoscopes
01/2004
1Duodenoscopes
12/2003
1Liver Transplantation
05/2001